WAM
GCVRZ

Wealthspire Advisors (Maryland)’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,332
Closed -$1K – 2541
2019
Q1 		$1K Buy
1,332
+532
+67% +$248 ﹤0.01% 2459
2018
Q4 		$0 Hold
800
– – ﹤0.01% 2700
2018
Q3 		$0 Hold
800
– – ﹤0.01% 2639
2018
Q2 		$0 Buy
+800
New +$373 ﹤0.01% 2728
2016
Q4 		– Sell
-800
Closed -$271 – 1947
2016
Q3 		$0 Buy
+800
New +$203 ﹤0.01% 1907

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s GCVRZ Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2019, closing a stake of 1,332 shares — an estimated $1K sold.

Wealthspire Advisors (Maryland) first reported a position in GCVRZ in Q3 2016 and held it in 5 quarters. The position peaked at $1K in Q1 2019. 104 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Sanofi Contingent Value Rights position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,332 Sanofi Contingent Value Rights shares in Q2 2019, an estimated $1K.
  • Wealthspire Advisors (Maryland) first reported a position in Sanofi Contingent Value Rights in Q3 2016 and held it in 5 quarters.
  • Wealthspire Advisors (Maryland)'s Sanofi Contingent Value Rights position peaked at $1K in Q1 2019.
  • 104 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.